Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EMA: Five-Year Regulatory Network Strategy Still ‘Valid And Relevant’ At Midway Point

Dec 21 2023

• By Eliza Slawther

European Union flag with covid-19 coronavirus in background — Antimicrobial resistance was a priority area within the European medicines agencies network strategy • Source: Shutterstock/Hyserb

Related Content

Bigger Trials, More RWE Needed for Future Crisis Response, Say EU Regulators

Dec 04 2023

EU Parliament Says Pharma IP & Trade Secrets Must Be Protected Under Health Data Space

Dec 01 2023

EU Plans To Trial Antimicrobial Voucher Scheme For 15 Years

May 02 2023

EU Pharma Revision: Legislators Prepare For Long-Haul Debate

May 25 2023

EMA Clarifies Questions Over Biosimilar Interchangeability

Feb 07 2023

EU HTA Regulation: Tight Deadlines & The Future Of Collaboration

Oct 19 2023

EU Panel Sets Ambitious Big Data Workplan

Sep 15 2020

EMA Begins Setting Up New Bodies To Tackle Drug Shortages

Mar 02 2022

Additional Topics

Europe EU Research & Development Regulation Policy Market Access Innovation Digital Health Artificial Intelligence BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window